Advanced Enzyme Technologies Ltd. Financials

NSE BSE

15:55 Sep 12

Advanced Enzyme Technologies Ltd.

Sector Pharmaceuticals & Biotechnology Industry Biotechnology

338.70

-1.60 (-0.47%)

Sector Pharmaceuticals & Biotechnology Industry Biotechnology

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Biotechnology

338.70

-1.60 (-0.47%)
15:55 Sep 12

Quality

46/100
Medium Financial Strength

Valuation

36/100
Mid Valuation

Technical

62/100
Technically Moderately Bullish

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM 2025
Net Sales	529.38	540.64	623.87	636.91	668.3
Operating Expenses +	327.96	384.19	419.41	442.47	468.57
Raw Material	130.33	127.53	155.47	161.96	165.72
Increase Decrease in Cost	-20.6	4.28	-10.89	-10.1	1.93
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	103.96	114.8	128.37	141.54	146.59
Miscellaneous Expenses	114.41	137.62	146.5	149.07	154.33
Operating Profit	201.42	156.45	204.46	194.44	199.73
Other Income	6.42	25.46	36.66	33.04	34.89
Depreciation	34.98	35.03	35.24	36.56	37.57
Interest	1.8	2.42	2.93	3.56	3.44
Profit before tax and exceptio..	171.06	144.45	202.95	187.36	193.61
Exceptional Items	0	-4.06	-15.13	0	0
PBT	171.06	140.39	187.82	187.36	193.61
Provision for Taxation	47.26	36.52	50.87	53.39	54.15
Net Profit	123.8	103.87	136.95	133.97	139.44
NET Profit after MI	119.58	105.64	133.3	131.12	136.89
EPS	10.68	9.45	11.92	11.72	12.24
Operating Profit Margin (%)	38.05	28.94	32.77	30.53	29.89
Net Profit Margin (%)	22.59	19.54	21.37	20.59	20.48

All Data in Percentage (%)

	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
Promoter	43.10	43.10	42.90	43.00	43.00
FII	23.40	11.90	12.60	12.60	12.00
MF	5.50	5.40	5.60	5.60	5.80
Others	3.00	2.80	2.50	2.40	2.30

Promoter Non-Promoter

Shareholder	Shares	Holding %

Download Our App On: